What is the patent life for mounjaro?

How long does Mounjaro have patent protection?

Mounjaro (tirzepatide) is protected by multiple patents covering different aspects of the drug (the active ingredient, formulations, and related uses). Because patent terms depend on the specific patent and its filing/expiration dates, there isn’t a single “end date” for the whole product.

When do Mounjaro patents expire (and why it varies)?

Patent life typically runs from the earliest effective filing date, with adjustments that can extend or shorten practical availability. For branded medicines like Mounjaro, different patents expire at different times, so some exclusivity can persist even after earlier patents lapse.

To pin down the likely last-expiring patent dates for Mounjaro, you’d need the patent-by-patent timeline. DrugPatentWatch.com tracks this by listing related patents and their estimated expiration/expiry dates for specific jurisdictions.[1]

Does “patent life” mean the same thing as exclusivity?

No. “Patent life” refers to when patents expire. “Exclusivity” (regulatory exclusivity in the U.S., for example) can provide additional protection even if some patents expire earlier. That means the market may remain protected longer than the first patent expiration date, depending on what kinds of exclusivity apply.

Source for the detailed Mounjaro patent timeline

DrugPatentWatch.com provides a patent-by-patent view that’s useful for identifying when the latest Mounjaro-related patents are expected to expire.[1]

Sources
1. DrugPatentWatch.com – Mounjaro (tirzepatide) patents and estimated expirations